Get the Stockscreener App
0.3451
0.63%
-0.0049
Nexalin Technology Inc stock is traded at $0.3451, with a volume of 77,916.
It is down -0.63% in the last 24 hours and down -27.16% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$0.35
Open:
$0.34
24h Volume:
77,916
Relative Volume:
0.14
Market Cap:
$7.66M
Revenue:
$275.60K
Net Income/Loss:
$-8.33M
P/E Ratio:
-0.7471
EPS:
-0.4619
Net Cash Flow:
$-5.40M
1W Performance:
+2.17%
1M Performance:
-27.16%
6M Performance:
-13.05%
1Y Performance:
-55.65%
1-Day Range:
$0.335
$0.3599
1-Week Range:
$0.335
$0.369
52-Week Range:
$0.305
$2.00
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
0.3479 | 7.70M | 275.60K | -8.33M | -5.40M | -0.4619 |
ABT
Abbott Laboratories
|
109.67 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
331.78 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.57 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.48 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.68 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nexalin Technology Inc Stock (NXL) Latest News
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk - TipRanks
Nexalin Technology Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Nexalin Technology earnings missed, revenue fell short of estimates By Investing.com - Investing.com South Africa
Nexalin Technology earnings missed, revenue fell short of estimates - Investing.com
Nexalin Technology Inc. (NASDAQ: NXL) Share Price, NXL Stock News, NXL Share Price & Updates - Kalkine
Nexalin Technology, Inc. 2Q 2026: Revenue $12.16K, EPS ($0.11) — 10-Q Summary - TradingView
Nexalin Technology (NXL) flags going concern risk as losses mount and Nasdaq warns - Stock Titan
Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexalin Technology | 8-K: Current report - Moomoo
Nexalin Technology Inc (NXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nexalin Technology Inc (NXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nexalin Technology Inc (NXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Nexalin Expands and Extends Houston Headquarters Lease Commitment - The Globe and Mail
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls - The Globe and Mail
Nexalin Technology Inc (NXL) Institutional Confidence - TradingKey
Nexalin Technology Received Notice of Delisting - TradingView
NXL|Nexalin Technology Inc|Price:0.353|Chg%:+0.014 - TradingKey
Nexalin Technology Inc (NXL) Cash Flow - TradingKey
Nexalin Technology Inc (NXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NXL|Nexalin Technology Inc|Price:0.500|Chg%:+0.019 - TradingKey
Nexalin Technology Inc (NXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nexalin Technology Inc (NXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
NXL|Nexalin Technology Inc|Price:0.481|Chg%:+0.013 - TradingKey
Nexalin Technology, Inc. Revenue Breakdown – NASDAQ:NXL - TradingView
Nexalin Technology (NXL) Registration filing Summary - Quartr
Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life - True North Radio Network
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre‑Revenue Biotech Advances Pipeline - dars.gov.et
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Misses Estimates Amid Pre-Revenue Development StageFinancial Summary - po-news-eg.net
Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance LevelATR Stop - dars.gov.et
NXL | Nexalin Technology, Inc. Common Executive Compensation - Quiver Quantitative
Nexalin Technology | ARS: Annual Report to Security Holders - Moomoo
Form DEF 14A Nexalin Technology Inc For: 10 July By Investing.com - Investing.com Nigeria
Nexalin Technology (NXL) plans new 7M-share incentive pool and reverse split authority - Stock Titan
Form DEF 14A Nexalin Technology Inc For: 10 July - Investing.com India
Nexalin Technology (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage ContinuesFinal Results - DonanımHaber
Enterprise value to revenue forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to book forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to sales forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
Price to earnings forward of Nexalin Technology, Inc. – NASDAQ:NXL - TradingView
NXL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines 5%Margin Compression Risk - dars.gov.et
Form PRE 14A Nexalin Technology Inc For: 29 June By Investing.com - Investing.com South Africa
Nexalin Technology (NXL) seeks shareholder votes for equity plan, reverse split - Stock Titan
NexaLine Technology Registers 1.2 Million Shares for Resale - Moomoo
Nexalin Technology | PRE 14A: Preliminary proxy statements relating to merger or acquisition - Moomoo
Nexalin Technology Secures US Patent for Deep-Brain Stimulation Targeting Insomnia - Sleep Review
Nexalin Technology Inc. (NXL) Q1 2026 Earnings: EPS Miss Amid Pre-Revenue Stage, Stock Rises 4%Earnings Season Preview - dars.gov.et
Nexalin Technology, Inc. Actuals & Estimates (NASDAQ:NXL) - TradingView
$Nexalin Technology (NXL.US)$ - Moomoo
Nexalin Technology Inc (NXLIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NXL Forecast — Price Target — Prediction for 2027 - TradingView
NXL Stock Price, Quote & Chart - ChartMill
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):